Among the different biomarkers predicting response in chronic lymphocytic leukemia (CLL), the most influential parameters are the mutational status of the IGHV genes and the presence of TP53 gene disruptions. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.